Kinetics, prognostic and predictive values of ESR1 circulating mutations in metastatic breast cancer patients progressing on aromatase inhibitor

PURPOSE: To assess the prognostic and predictive value of circulating ESR1 mutation and its kinetics before and after progression on aromatase inhibitor (AI) treatment. PATIENTS AND METHODS: ESR1 circulating D538G and Y537S/N/C mutations were retrospectively analyzed by digital droplet PCR after fir...

Descripción completa

Detalles Bibliográficos
Autores principales: Clatot, Florian, Perdrix, Anne, Augusto, Laetitia, Beaussire, Ludivine, Delacour, Julien, Calbrix, Céline, Sefrioui, David, Viailly, Pierre-Julien, Bubenheim, Michael, Moldovan, Cristian, Alexandru, Cristina, Tennevet, Isabelle, Rigal, Olivier, Guillemet, Cécile, Leheurteur, Marianne, Gouérant, Sophie, Petrau, Camille, Théry, Jean-Christophe, Picquenot, Jean-Michel, Veyret, Corinne, Frébourg, Thierry, Jardin, Fabrice, Sarafan-Vasseur, Nasrin, Di Fiore, Frédéric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Priority Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342678/
https://www.ncbi.nlm.nih.gov/pubmed/27801670
http://dx.doi.org/10.18632/oncotarget.12950

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342678/
https://www.ncbi.nlm.nih.gov/pubmed/27801670
http://dx.doi.org/10.18632/oncotarget.12950

Ejemplares similares